David Cordani has officially taken the helm of the health insurance company, replacing retiring CIGNA Chairman and CEO Ed Hanway.
CIGNA Corporation rang in the New Year with a new chief executive. David Cordani has officially taken the helm of the health insurance company, replacing retiring CIGNA Chairman and CEO Ed Hanway.
Cordani, 43, has been with the company 14 years. He became president of CIGNA HealthCare in 2005, and chief operating officer in 2008.
He takes the reins of the 200-year-old company that saw its stock price rise 98% in 2009 amid an uncertain economy as Congress debated the healthcare bill. He plans to maintain that type of growth by expanding in other countries.
"CIGNA's overall strategy for 2010 and beyond is focused on targeted global growth, an individual customer focus and improving health, well-being, and security for those we serve around the world," Cordani says.
CIGNA is already an international company with products and services including global expatriate benefits, global life, accident and health, and European health care. However, countries such as Indonesia and China, with their fast-growing middle classes, provide a ripe market for insurance coverage. Cordani also expects growth in the U.S. market for disability insurance and administrative services the company provides to companies.
CIGNA also named Isaiah “Ike” Harris as chairman of the company’s board of directors. Harris, 57, became a director at Cigna in 2005.
Less than a week after officially being named as CEO, Cordani named his executive leadership team for the company:
A search is under way for a leader who will be president of a new position over U.S. Commercial for CIGNA, including U.S. products, marketing, national accounts, middle-market, individual segment, select segment, seniors, CIGNA medical group, third-party arrangements, emerging markets, COLI and strategic alliances.
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen